Company / Shareholders' Equity
Regenerative Medical Technology Group Inc. Shareholders' Equity History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$34.7M
FY2025
5-year range
-$34.7M / -$6.8M
FY2021-FY2025
Trend
-27.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Regenerative Medical Technology Group Inc. reports negative total equity of -$35M in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$35M in FY2025.
Declined from -$22M to -$35M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Regenerative Medical Technology Group Inc.'s shareholders' equity has declined for 5 consecutive years.
- In FY2025, shareholders' equity decreased 27.0% year-over-year.
- Peak shareholders' equity was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -19.75 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$34.7M | -27.0% |
| FY2024 | -$27.4M | -25.5% |
| FY2023 | -$21.8M | -81.9% |
| FY2022 | -$12.0M | -77.3% |
| FY2021 | -$6.8M | -5.4% |
| FY2020 | -$6.4M | +12.9% |
| FY2019 | -$7.4M | -62.1% |
| FY2018 | -$4.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026